James Cusack, MD, FACS, Surgical Oncologist at Massachusetts General Hospital, has been named a 2017 Top Doctor in Boston, Massachusetts. Top Doctor Awards is dedicated to selecting and honoring those healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care.
Dr. James Cusack is an experienced and esteemed surgeon who has been in practice for more than three decades. His acclaimed career in medicine began in 1986 when he graduated from Emory University School of Medicine in Atlanta, Georgia. Dr. Cusack then completed an internship and residency at the Tufts University’s New England Medical Center in Boston, followed by fellowships at Brigham and Women’s Hospital in Boston, and at the University of Texas MD Anderson Cancer Center in Houston.
Dr. Cusack is certified by the American Board of General Surgery and he has become renowned as one of the nation’s leading experts on surgical oncology, both as a practitioner and as an academic. He is particularly noted as an expert on locally advanced, recurrent, and metastatic cancer, and he is also at the forefront of medical research in this field at the MGH Cancer Center.
Alongside his practice, Dr. Cusack serves as an Associate Professor of Surgery at the prestigious Harvard Medical School, and he is also Director of Harvard’s Peritoneal Surface Malignancy Program as well as a Director of Global Surgery Initiative. He has been awarded the coveted title of Fellow of the American College of Surgeons, and is the author of over a hundred medical papers and book chapters. His expertise and commitment makes Dr. James Cusack a very worthy winner of a 2017 Top Doctor Award.
About Top Doctor Awards
Top Doctor Awards specializes in recognizing and commemorating the achievements of today’s most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors.
SOURCE: Top Doctor Awards
This press release is distributed by PR NewsChannel. Your News. Everywhere.